Rational Modification of a Candidate Cancer Drug for Use Against Chagas Disease
- 24 February 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (6) , 1639-1647
- https://doi.org/10.1021/jm801313t
Abstract
Chagas disease is one of the major neglected diseases of the world. Existing drug therapies are limited, ineffective, and highly toxic. We describe a novel strategy of drug discovery of adapting an existing clinical compound with excellent pharmaceutical properties to target a pathogenic organism. The protein farnesyltransferase (PFT) inhibitor tipifarnib, now in phase III anticancer clinical trials, was previously found to kill Trypanosoma cruzi by blocking sterol 14α-demethylase (14DM). We rationally developed tipifarnib analogues that display reduced affinity for human PFT to reduce toxicity while increasing affinity for parasite 14DM. The lead compound has picomolar activity against cultured T. cruzi and is efficacious in a mouse model of acute Chagas disease.Keywords
This publication has 28 references indexed in Scilit:
- Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas diseaseNature Medicine, 2008
- Efficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein FarnesyltransferaseAntimicrobial Agents and Chemotherapy, 2007
- Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5]Bioorganic & Medicinal Chemistry Letters, 2006
- Comparative Efficacies of TAK-187, a Long-Lasting Ergosterol Biosynthesis Inhibitor, and Benznidazole in Preventing Cardiac Damage in a Murine Model of Chagas' DiseaseAntimicrobial Agents and Chemotherapy, 2005
- Crystal Structures of the Anticancer Clinical Candidates R115777 (Tipifarnib) and BMS-214662 Complexed with Protein Farnesyltransferase Suggest a Mechanism of FTI SelectivityBiochemistry, 2004
- Synthesis Routes Towards the Farnesyl Protein Transferase Inhibitor ZARNESTRATMEuropean Journal of Organic Chemistry, 2004
- Enantioselective Syntheses of Nonracemic Benzyl-α-dAlcohols via Catalytic Transfer-Hydrogenation with Ru, Os, Rh, and Ir CatalystsOrganometallics, 2002
- Reactions of 4-chloro-1-nitrobenzene with o-substituted phenylacetonitriles; Synthesis of 8-chloro-1-methyl(and methylthiomethyl)-6-(2-substituted phenyl)-4H-s-triazolo[4,3-a]-1,4-benzodiazepinesCollection of Czechoslovak Chemical Communications, 1987
- Syntheses and reactions of the first dithia[3.1.3.1]metacyclophanes, [2.1.2.1]metacyclophanes, and [2.1.2.1]metacyclophanedienesThe Journal of Organic Chemistry, 1984
- Reaction Rates by Distillation. I. The Etherification of Phenylcarbinols and the Transetherification of their EthersJournal of the American Chemical Society, 1949